The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-3-[1-(2,2-dimethoxyethyl)-4-(4-fluorophenyl)-5-[2-[(3-methoxy-1-methyl-butyl)amino]-4-pyridyl]imidazol-2-yl]sulfanylprop-2-enoic acid ID: ALA5287474
Chembl Id: CHEMBL5287474
Max Phase: Preclinical
Molecular Formula: C27H33FN4O5S
Molecular Weight: 544.65
Associated Items:
Names and Identifiers Canonical SMILES: COC(C)CC(C)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC(OC)OC)ccn1
Standard InChI: InChI=1S/C27H33FN4O5S/c1-17(14-18(2)35-3)30-22-15-20(10-12-29-22)26-25(19-6-8-21(28)9-7-19)31-27(38-13-11-23(33)34)32(26)16-24(36-4)37-5/h6-13,15,17-18,24H,14,16H2,1-5H3,(H,29,30)(H,33,34)/b13-11-
Standard InChI Key: JVBXQJUJOCLPLK-QBFSEMIESA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.65Molecular Weight (Monoisotopic): 544.2156AlogP: 5.29#Rotatable Bonds: 14Polar Surface Area: 107.73Molecular Species: ACIDHBA: 9HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.14CX Basic pKa: 7.24CX LogP: 2.89CX LogD: 2.51Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -0.64
References 1. Ahamad S, Bhat SA.. (2022) The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease., 65 (24.0): [PMID:36490325 ] [10.1021/acs.jmedchem.2c00799 ]